# DAPSONE
> **ANDA212383** · Abbreviated New Drug Application (Generic) · Sponsor: ENCUBE · Approved 2023-10-13
## Drug
- **FDA Application Number:** ANDA212383
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE GEL, 5%
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ENCUBE
- **Manufacturer:** Encube Ethicals, Inc.
- **First approval:** 2023-10-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212383)
---
*AI Analytics · CC0 1.0*